Moderna, Inc. (MRNA)
NASDAQ: MRNA · IEX Real-Time Price · USD
121.14
-0.18 (-0.15%)
At close: Jul 19, 2024, 4:00 PM
121.83
+0.69 (0.57%)
Pre-market: Jul 22, 2024, 7:32 AM EDT
Moderna Revenue
Moderna had revenue of $5.15B in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $167.00M. In the year 2023, Moderna had annual revenue of $6.85B.
Revenue (ttm)
$5.15B
Revenue Growth
-65.78%
P/S Ratio
9.01
Revenue / Employee
$920,179
Employees
5,600
Market Cap
46.43B USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 6.85B | -12.42B | -64.45% |
| Dec 31, 2022 | 19.26B | 792.00M | 4.29% |
| Dec 31, 2021 | 18.47B | 17.67B | 2,200.25% |
| Dec 31, 2020 | 803.00M | 743.00M | 1,238.33% |
| Dec 31, 2019 | 60.00M | -75.07M | -55.58% |
| Dec 31, 2018 | 135.07M | -70.76M | -34.38% |
| Dec 31, 2017 | 205.83M | 97.43M | 89.88% |
| Dec 31, 2016 | 108.40M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CVS Health | 360.94B |
| McKesson | 308.95B |
| Cencora | 276.54B |
| Humana | 109.24B |
| Takeda Pharmaceutical | 28.16B |
| Becton, Dickinson and Company | 19.72B |
| IQVIA Holdings | 15.07B |
| Alcon | 9.56B |
MRNA News
- 1 day ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA - GlobeNewsWire
- 3 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - MRNA - PRNewsWire
- 12 days ago - Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024 - Accesswire
- 14 days ago - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Moderna, Inc. - MRNA - GlobeNewsWire
- 19 days ago - Moderna Receives HHS Grant to Develop a Bird Flu Vaccine - Investopedia
- 20 days ago - US awards Moderna $176 million to produce bird flu vaccine - Reuters
- 20 days ago - Moderna gets U.S. government funding for bird-flu vaccine development - Market Watch
- 20 days ago - Moderna Scores Federal Funding For mRNA Bird Flu Vaccine As Pandemic Fears Grow - Forbes